AI-generated summary
The authors pooled six randomized controlled trials of 205 injured athletes to examine whether photobiomodulation reduces musculoskeletal pain and shortens return to play. They report a positive pain-reduction effect compared with control groups, but found that the two trials on return to play did not support a benefit. The authors note that evidence on return to play is limited.
- Participants
- 205
- Studies included
- 6
- Who or what was studied
- Competitive and recreational injured athletes with a mean age of 24 years
- Limits stated in the abstract
- The abstract states that evidence on time to return to play is limited, with only two trials assessing it.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Meta-analysis. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.